Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

American Journal of Epidemiology

Volumn 157, Issue 5, 2003, Pages 467-471

  Des Jarlais, Don C ^a,b   Diaz, Theresa ^c   Perlis, Theresa ^b   Vlahov, David ^c   Maslow, Carey ^b   Latka, Mary ^c   Rockwell, Russell ^b   Edwards, Vincent ^c   Friedman, Samuel R ^b   Monterroso, Edgar ^d   Williams, Ian ^d   Garfein, Richard S ^d  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cohort studies; Hepatitis B virus; Hepatitis C like viruses; HIV; Injections, intravenous; Substance related disorders

Indexed keywords

DISEASE INCIDENCE; DRUG USER; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; YOUNG POPULATION;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE TRANSMISSION; DRUG ABUSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SUBSTANCE ABUSE; UNITED STATES; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; INTERVIEWS; MALE; NEW YORK CITY; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

UNITED STATES;

EID: 0037372517     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf222     Document Type: Article

References (13)

1. Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med 2000;67:423-8.
2. Levine OS, Vlahov D, Nelsen KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 1994;16:418-36.
3. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
4. Levine OS, Vlahov D, Brookmeyer R, et al. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis 1996;173: 579-83.
5. Coyle SR, Boruch RF, Turner CF, eds. Evaluating AIDS prevention programs. Expanded ed. Washington, DC: National Academy Press, 1991.
6. Culver J. Preventing transmission of blood-borne pathogens: a compelling argument for effective device-selection strategies. Am J Infect Control 1997;25:430-3.
7. Garfein R, Doherty M, Monterroso E, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:S11-S19.
8. van Beek I, Dwyer R, Dore GJ, et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998;317:433-7.
9. Des Jarlais DC, Perlis T, Friedman SR, et al. Declining sero-prevalence in a very large HIV epidemic: injecting drug users in New York City, 1991-1996. Am J Public Health 1998;88: 1801-6.
10. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injecting drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000;90: 352-9.
11. Thorpe L, Ouellet L, Levy J, et al. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000;182:1588-94.
12. Hagan H, Thiede H, Weiss NS, et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42-6.
13. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001;91:23-30.